Cancer
Malignant Lung Neoplasm
CI-CAN-00001140Explore in graph →
Top-level2,650 active trials51 approved drugs619 evidence items
- NCIt
- C7377
- OncoTree
- LUNG
- ICD-10
- C33-C34
- DOID
- 1324
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001140Explore in graph →
Clinical trials
11,127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,491)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02804217 | Acquired Resistant Mechanism of the First-generation EGFR TKIs | unknown | — | 60 | Zhejiang Cancer HospitalOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT02804646 | Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma | unknown | Phase 4 | 100 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 21, 2016 | clinicaltrials |
| NCT02803619 | A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis | unknown | — | 60 | Peking Union Medical College HospitalOTHER | 1 | Jun 17, 2016 | clinicaltrials |
| NCT02105168 | Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment(MSN) | unknown | N/A | 2,200 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT02788058 | A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy | unknown | Phase 2 | 76 | First People's Hospital of HangzhouOTHER | 0 | Jun 2, 2016 | clinicaltrials |
| NCT01882621 | Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients | unknown | Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02651441 | D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC) | unknown | Phase 1 / Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02780778 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT02778893 | Conmana Combined With Thalidomide to Treat NSCLC | unknown | Phase 4 | 67 | Henan Provincial People's HospitalOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT01745445 | Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC)(SCLC) | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT02772107 | Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 132 | Chinese PLA General HospitalOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT01892800 | Right Side of Heart Function After Lung Surgery | unknown | — | 25 | University of GlasgowOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT02771756 | The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy | unknown | N/A | 300 | Chinese Academy of Medical SciencesOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT02766348 | Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients | unknown | Phase 2 | 60 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 9, 2016 | clinicaltrials |
| NCT02755337 | The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase(EVALUATE) | unknown | — | 70 | Dr. Soetomo General HospitalOTHER_GOV | 1 | Apr 28, 2016 | clinicaltrials |
| NCT02738346 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013(CBPC) | unknown | Phase 3 | 164 | University Hospital, AngersOTHER_GOV | 1 | Apr 25, 2016 | clinicaltrials |
| NCT02462356 | Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer(MVUVLC) | unknown | N/A | 70 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT02737735 | The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation | unknown | Phase 1 | 200 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02738593 | Detection Cell Free DNA in Lung Cancer Patients | unknown | — | 124 | Sun Yat-sen UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02738684 | A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test | unknown | — | 100 | Southwest Hospital, ChinaOTHER | 0 | Apr 14, 2016 | clinicaltrials |
| NCT02738723 | SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC | unknown | Phase 2 | 50 | Third Military Medical UniversityOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02738983 | RT Plus EGFR-TKI for Wild-type NSCLC | unknown | Phase 2 | 22 | Hangzhou Cancer HospitalOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02736916 | HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer | unknown | N/A | 3 | General Hospital of Ningxia Medical UniversityOTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT02733107 | The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 25 | Third Military Medical UniversityOTHER | 1 | Apr 12, 2016 | clinicaltrials |
| NCT00690963 | Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating | unknown | Phase 1 / Phase 2 | 12 | AHS Cancer Control AlbertaOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT01977235 | Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer(TDICC) | unknown | Phase 2 | 110 | Third Military Medical UniversityOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT02031601 | Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer(TCL-1) | unknown | Phase 4 | 250 | Qilu Hospital of Shandong UniversityOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT00122239 | A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers | unknown | — | 13 | AHS Cancer Control AlbertaOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT02618590 | A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure | unknown | — | 800 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT02708667 | An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients | unknown | — | 50 | Sun Yat-sen UniversityOTHER | 1 | Mar 15, 2016 | clinicaltrials |
| NCT02704767 | Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma | unknown | Phase 2 | 60 | First Affiliated Hospital of Kunming Medical UniversityOTHER | 0 | Mar 10, 2016 | clinicaltrials |
| NCT02691871 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR | unknown | Phase 1 | 20 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Feb 25, 2016 | clinicaltrials |
| NCT02037997 | Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC | unknown | Phase 2 | 80 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02688673 | DC Vaccine Combined With CIK Cells in Patients With SCLC | unknown | Phase 1 / Phase 2 | 30 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 0 | Feb 23, 2016 | clinicaltrials |
| NCT02686775 | The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients(PACO) | unknown | N/A | 306 | Danish Cancer SocietyOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT02270853 | SAS in Patients With Bronchial Carcinoma(SAS CA) | unknown | N/A | 100 | RWTH Aachen UniversityOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT01393080 | Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients(NSCLC) | unknown | N/A | 160 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT02665390 | Percutaneous Cryoablation Peripheral Lung Cancer(PCPLC) | unknown | N/A | 30 | Shanghai Chest HospitalOTHER | 0 | Feb 12, 2016 | clinicaltrials |
| NCT01784107 | A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 45 | Gachon University Gil Medical CenterOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT02669719 | Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC | unknown | Phase 2 | 70 | Shanghai Chest HospitalOTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT01801852 | Autologous Natural Killer T Cells Infusion for the Treatment of Cancer | unknown | N/A | 300 | Chinese PLA General HospitalOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT02663492 | Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients | unknown | N/A | 300 | Tongji UniversityOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02661009 | Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method) | unknown | — | 1,000 | GenoSaberINDUSTRY | 0 | Jan 21, 2016 | clinicaltrials |
| NCT02650544 | Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression | unknown | Phase 2 | 236 | Sun Yat-sen UniversityOTHER | 1 | Jan 8, 2016 | clinicaltrials |
| NCT02644889 | EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment | unknown | — | 100 | GenoSaberINDUSTRY | 0 | Jan 7, 2016 | clinicaltrials |
| NCT02647164 | The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring | unknown | — | 360 | GenoSaberINDUSTRY | 0 | Jan 6, 2016 | clinicaltrials |
| NCT02648087 | Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer(NEOSAS) | unknown | N/A | 1,200 | University Hospital, AngersOTHER_GOV | 0 | Jan 6, 2016 | clinicaltrials |
| NCT02643407 | Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer | unknown | Phase 3 | 488 | Guangdong Association of Clinical TrialsOTHER | 1 | Dec 31, 2015 | clinicaltrials |
| NCT00973310 | Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer | unknown | Phase 2 | 50 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT01255059 | GWAS Research of Lung Cancer in Tianjin | unknown | — | 500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Jun 21, 2016source: clinicaltrials